The Impact of Obesity on Cardiovascular Diseases: Heart Failure
References
- Bozkurt B, Ahmad T, Alexander KM, et al. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 Oct 1;29(10):1412-51. doi: 10.1016/j.cardfail.2023.07.006
- CDC [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; c2025.
Adult Obesity Facts ; 2020 [cited 2024 Oct 17]. Available from:https://www.cdc.gov/obesity/php/data-research/adult-obesity-facts.html - Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019 Dec 19;381(25):2440-2450. doi: 10.1056/NEJMsa1909301
- Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963
- Clerkin KJ, Naka Y, Mancini DM, Colombo PC, Topkara VK. The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. JACC Hear Fail. 2016 Oct 1;4(10):761-768. doi: 10.1016/j.jchf.2016.05.010
- Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes. Obes Surg. 2016 May;26(5):1030-40. doi: 10.1007/s11695-015-1866-5
- Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018 Feb 10;391(10120):572-580. doi: 10.1016/S0140-6736(17)32520-5
- Pandey A, Patel KV, Vaduganathan M, et al. Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction. JACC Hear Fail. 2018 Dec;6(12):975-982. doi: 10.1016/j.jchf.2018.09.006
- Aune D, Sen A, Norat T, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: A systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016 Feb 16;133(7):639-49. doi: 10.1161/CIRCULATIONAHA.115.016801
- Vest AR, Chan M, Deswal A, et al. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019 May;25(5):380-400. doi: 10.1016/j.cardfail.2019.03.007
- Kindel TL, Higgins RM, Lak K, et al. Bariatric surgery in patients with advanced heart failure: A proposed multi-disciplinary pathway for surgical care in medically complex patients. Surgery. 2021 Sep;170(3):659-663. doi: 10.1016/j.surg.2021.04.036
- Hawkins RB, Go K, Raymond SL, Ayzengart A, Friedman J. Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant. Surg Obes Relat Dis. 2018 Sep;14(9):1269-1273. doi: 10.1016/j.soard.2018.04.005
- Van Veldhuisen SL, Gorter TM, Van Woerden G, et al. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2022 May 21;43(20):1955-1969. doi: 10.1093/eurheartj/ehac071
- Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease A Scientific Statement From the American Heart Association. Circulation. 2021 May 25;143(21):E984-1010. doi: 10.1161/CIR.0000000000000973
- Grassi G, Seravalle G, Quarti-Trevano F, et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms. Hypertension. 2007 Mar;49(3):535-41. doi: 10.1161/01.HYP.0000255983.32896.b9
- Csige I, Ujvárosy D, Szabó Z, et al. The Impact of Obesity on the Cardiovascular System. J Diabetes Res. 2018 Nov 4;2018:
3407306 . doi: 10.1155/2018/3407306 - Kuperstein R, Hanly P, Niroumand M, Sasson Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol. 2001 Jun 1;37(7):1957-62. doi: 10.1016/s0735-1097(01)01242-6
- Asferg CL, Nielsen SJ, Andersen UB, et al. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension. 2013 Jul;62(1):147-53. doi: 10.1161/HYPERTENSIONAHA.111.00791
- Fukushima A, Lopaschuk GD. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. Biochim Biophys Acta. 2016 Oct;1861(10):1525-34. doi: 10.1016/j.bbalip.2016.03.020
- Obokata M, Reddy YNV, Pislaru S V., Melenovsky V, Borlaug BA. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction. Circulation. 2017 Jul 4;136(1):6-19. doi: 10.1161/CIRCULATIONAHA.116.026807
- Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res. 2014 Oct;164(4):345-56. doi: 10.1016/j.trsl.2014.04.010
- Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Aug 7;116(6):627-36. doi: 10.1161/CIRCULATIONAHA.106.679779
- Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001 Sep;38(3):789-95. doi: 10.1016/s0735-1097(01)01448-6
- Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009 May;53(21):1925-32. doi: 10.1016/j.jacc.2008.12.068
- Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008 Jul;156(1):13-22. doi: 10.1016/j.ahj.2008.02.014
- Vecchié A, Dallegri F, Carbone F, et al. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med. 2018 Feb;48:6-17. doi: 10.1016/j.ejim.2017.10.020
- Lavie CJ, Cahalin LP, Chase P, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013 Mar;88(3):251-8. doi: 10.1016/j.mayocp.2012.11.020
- Kitzman DW, Brubaker P, Morgan T, et al. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2016 Jan 5;315(1):36-46. doi: 10.1001/jama.2015.17346
- Evangelista LS, Doering LV, Lennie T, et al. Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure. Am J Cardiol. 2006 Mar 15;97(6):886-90. doi: 10.1016/j.amjcard.2005.10.025
- Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail. 2005 May-Jun;11(3):118-23. doi: 10.1111/j.1527-5299.2005.03827.x
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563
- Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141
- Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827
- Withaar, C, Meems, L, Nollet, E, et al. The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF. JACC Basic Transl Sci. 2023 Jul 26;8(10):1298-1314. doi: 10.1016/j.jacbts.2023.05.012
- Liang B, Gu N. Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE. Cardiovasc Diabetol. 2020 Jul 6;19(1):106. doi: 10.1186/s12933-020-01088-3
- Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013
- Berger S, Meyre P, Blum S, et al. Bariatric surgery among patients with heart failure: a systematic review and meta-analysis. Open Heart. 2018 Dec 9;5(2):
e000910 . doi: 10.1136/openhrt-2018-000910 - Sargsyan N, Chen JY, Aggarwal R, Fadel MG, Fehervari M, Ashrafian H. The effects of bariatric surgery on cardiac function: a systematic review and meta-analysis. Int J Obes (Lond). 2024 Feb;48(2):166-176. doi: 10.1038/s41366-023-01412-3
- Sundström J, Bruze G, Ottosson J, Marcus C, Näslund I, Neovius M. Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment. Circulation. 2017 Apr 25;135(17):1577-1585. doi: 10.1161/CIRCULATIONAHA.116.025629
- Vest AR, Patel P, Schauer PR, et al. Clinical and Echocardiographic Outcomes After Bariatric Surgery in Obese Patients With Left Ventricular Systolic Dysfunction. Circ Heart Fail. 2016 Mar;9(3):
e002260 . doi: 10.1161/CIRCHEARTFAILURE.115.002260 - Greene SJ, Butler J, Albert NM, et al. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070
- Cappelletto C, Stolfo D, Orsini N, et al. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. Eur J Heart Fail. 2023 May;25(5):698-710. doi: 10.1002/ejhf.2795
- Khan MS, Fendler TJ, Butler J, Devore AD, Fonarow GC, Spertus JA. Abstract 14767: Obesity is Associated With Greater Intensity of Guideline Recommended Therapy in Patients With Heart Failure With Reduced Ejection Fraction in the CHAMP-HF Registry. Circulation. 2023 Nov 7;148(Suppl_1). doi: 10.1161/circ.148.suppl_1.14767
- Adamson C, Jhund PS, Docherty KF, et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail. 2021 Oct;23(10):1662-1672. doi: 10.1002/ejhf.2308
- Anker SD, Khan MS, Butler J, et al. Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. Eur J Heart Fail. 2023 Jan;25(1):117-127. doi: 10.1002/ejhf.2728
- Eli Lilly [Internet]. Indianapolis, IN: Eli Lilly; c2025.
Lilly’s tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity ; 2024 Aug 1 [cited 2024 Oct 23]. Available from:https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-successful-phase-3-study-showing-benefit - Lavie CJ, Mehra MR, Ventura HO. Body Composition and Advanced Heart Failure Therapy: Weighing the Options and Outcomes. JACC Heart Fail. 2016 Oct;4(10):769-771. doi: 10.1016/j.jchf.2016.07.007
- Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016 Jan 1;35(1):1-23. doi: 10.1016/j.healun.2015.10.023
- Jaiswal A, Truby LK, Chichra A, et al. Impact of Obesity on Ventricular Assist Device Outcomes. J Card Fail. 2020 Apr;26(4):287-297. doi: 10.1016/j.cardfail.2019.10.001.
- Challapalli J, Maynes EJ, O’Malley TJ, et al. Sleeve Gastrectomy in Patients with Continuous-Flow Left Ventricular Assist Devices: a Systematic Review and Meta-Analysis. Obes Surg. 2020 Nov;30(11):4437-4445. doi: 10.1007/s11695-020-04834-4
- daSilva-deAbreu A, Alhafez BA, Curbelo-Pena Y, et al. Bariatric surgery in obese patients with ventricular assist devices. BMC Res Notes. 2020 Aug 14;13(1):382. doi: 10.1186/s13104-020-05221-z
- Val FRD, Cheon O, Menser T, et al. Bariatric Surgery in End-Stage Heart Failure: Feasibility in Successful Attainment of a Target Body Mass Index. J Card Fail. 2020 Nov;26(11):944-947. doi: 10.1016/j.cardfail.2020.04.020
- Kindel TL, Higgins RM, Lak K, et al. Bariatric surgery in patients with advanced heart failure: A proposed multi-disciplinary pathway for surgical care in medically complex patients. Surgery. 2021 Sep;170(3):659-663. doi: 10.1016/j.surg.2021.04.036
- Al-Ani MA, Murray MR, Taha MB, et al. Impact of Laparoscopic Sleeve Gastrectomy on Cardiovascular Pharmacotherapy in Left Ventricular Assist Device Patients. J Cardiovasc Pharmacol. 2022 May 1;79(5):646-649. doi: 10.1097/FJC.0000000000001223
- Patel KV, Bahnson JL, Gaussoin SA, et al. Association of Baseline and Longitudinal Changes in Body Composition Measures with Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings from the Look AHEAD Trial. Circulation. 2020 Dec 22;142(25):2420-2430. doi: 10.1161/CIRCULATIONAHA.120.050941
- Look AHEAD Research Group; Gregg E, Jakicic J, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0
- Pandey A, Garg S, Khunger M, et al. Dose-Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis. Circulation. 2015 Nov 10;132(19):1786-94. doi: 10.1161/CIRCULATIONAHA.115.015853
- Pandey A, LaMonte M, Klein L, et al. Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure. J Am Coll Cardiol. 2017 Mar 7;69(9):1129-1142. doi: 10.1016/j.jacc.2016.11.081
- Zhou Y, Dai M, Huang T, et al. Association between BMI and Efficacy of SGLT2 Inhibitors in Patients with Heart Failure or at Risk of Heart Failure: A Meta-Analysis Based on Randomized Controlled Trials. Cardiology. 2024 Apr;149(2):104-116. doi: 10.1159/000535297
- Oyama K, Raz I, Cahn A, et al. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. Eur Heart J. 2022 Aug 14;43(31):2958-2967. doi: 10.1093/eurheartj/ehab530
- Thomas M, Magwire M, Gosch K, et al. Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):
E007682 . doi: 10.1161/CIRCOUTCOMES.120.007682 - Rao VU, Ziedonis K, Gunderman D, et al. Structured program for weight loss in heart failure patients: findings from a cardiology-driven obesity clinic. JACC Adv. 2024,3:
100741 . doi: 10.1016/j.jacadv.2023.100741
DOI: https://doi.org/10.14797/mdcvj.1511 | Journal eISSN: 1947-6108
Language: English
Page range: 44 - 52
Submitted on: Oct 26, 2024
Accepted on: Jan 14, 2025
Published on: Feb 18, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2025 Hatem Alansari, Gina Lazzara, Mohamad B. Taha, Janardhana R. Gorthi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.